KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Other Non-Current Assets (2016 - 2025)

Humana (HUM) has disclosed Other Non-Current Assets for 16 consecutive years, with $4.0 billion as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets changed N/A to $4.0 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $4.0 billion, a N/A change, with the full-year FY2022 number at $3.4 billion, down 22.81% from a year prior.
  • Other Non-Current Assets was $4.0 billion for Q3 2025 at Humana, up from $3.7 billion in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $4.6 billion in Q1 2022 to a low of $2.3 billion in Q2 2021.
  • A 4-year average of $3.6 billion and a median of $3.7 billion in 2023 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 105.78% in 2021, then dropped 22.81% in 2022.
  • Humana's Other Non-Current Assets stood at $4.4 billion in 2021, then dropped by 22.81% to $3.4 billion in 2022, then increased by 7.63% to $3.6 billion in 2023, then grew by 10.42% to $4.0 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Other Non-Current Assets are $4.0 billion (Q3 2025), $3.7 billion (Q2 2025), and $3.4 billion (Q1 2025).